arrow
Home
Aker BioMarine reports 17%...

Aker BioMarine reports 17% revenue growth in 2020 amid krill EPA/DHA launch and COVID-19 hurdles

The company also entered a research collaboration for its Lysoveta krill ingredient’s potential for Alzheimer’s

16 Feb 2021
-
Aa
+
Click Here
trans